Natera, Inc. (NTRA) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-26 21:37:46 ET
Natera, Inc. (NTRA) Q4 2025 Earnings Call February 26, 2026 4:30 PM EST
Company Participants
Mike Brophy - Chief Financial Officer
Steve Chapman - CEO & Director
Solomon Moshkevich - President of Clinical Diagnostics
Alexey Aleshin - GM of Oncology and ECD & Chief Medical Officer
John Fesko - President & Chief Business Officer
...
Read the full article on Seeking Alpha
For further details see:
Natera, Inc. (NTRA) Q4 2025 Earnings Call Transcript
Natera Inc.
NASDAQ: NTRA
NTRA Trading
-0.98% G/L:
$194.455 Last:
482,941 Volume:
$193.27 Open:
NTRA Latest News
February 28, 2026 04:57:00 am
3 Reasons Exelixis Stock Could Deliver Market?Beating Returns Over the Next Decade
February 27, 2026 10:05:00 am
Signatera(TM) MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation
NTRA Stock Data
$29,241,088,573
130,533,658
0.75%
312
N/A
Medical Diagnostics & Screening
Healthcare
US
Austin
